Bio-identical progesterone is not associated with an increased risk of breast cancer and actually decreases the risk of breast cancer.  Bio-identical progesterone is associated with a lower risk of heart disease and stroke as compared to synthetic progestins like Provera and is more effective. Patients report more satisfaction and fewer side effects